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Abstract
The authors investigated the effectiveness and specificity of the Penn Resiliency Program (PRP; J. 
E. Gillham, L. H. Jaycox, K. J. Reivich, M. E. P. Seligman, & T. Silver, 1990), a cognitive–
behavioral depression prevention program. Children (N = 697) from 3 middle schools were 
randomly assigned to PRP, Control (CON), or the Penn Enhancement Program (PEP; K. J. 
Reivich, 1996; A. J. Shatté, 1997), an alternate intervention that controls for nonspecific 
intervention ingredients. Children’s depressive symptoms were assessed through 3 years of 
follow-up. There was no intervention effect on average levels of depressive symptoms in the full 
sample. Findings varied by school. In 2 schools, PRP significantly reduced depressive symptoms 
across the follow-up relative to both CON and PEP. In the 3rd school, PRP did not prevent 
depressive symptoms. The authors discuss the findings in relation to previous research on PRP and 
the dissemination of prevention programs.
Keywords
depression; prevention; children; adolescence
Several cognitive–behavioral interventions show promise in preventing depressive 
symptoms in youths (for recent reviews, see Horowitz & Garber, 2006; Merry, McDowell, 
Hetrick, Bir, & Muller, 2004). Among these are the Coping with Stress Course (Clarke & 
Lewinsohn, 1995), the Resourceful Adolescent Program (RAP; Shochet, Whitefield, & 
Holland, 1997), the LISA-T Program (Pössel, Horn, Groen, & Hautzinger, 2004), and the 
Penn Resiliency Program1 (PRP; Gillham, Jaycox, Reivich, Seligman, & Silver, 1990). 
Despite this promise, however, depression prevention programs that demonstrate positive 
effects are rarely incorporated into school or clinical settings, and little is known about the 
effectiveness of most programs when delivered by the individuals who work in these 
settings.
In addition, when these programs do work, it is usually unclear whether the cognitive–
behavioral therapy skills or other nonspecific factors (e.g., time spent in a structured after-
school activity, attention from an adult, support from peers) are responsible. The majority of 
depression prevention studies compare cognitive–behavioral interventions with a no-
intervention control. Only a few studies have compared prevention programs with attention 
control groups or alternate interventions. Pattison and Lynd-Stevenson (2001) found that 
PRP did not significantly reduce or prevent depressive symptoms relative to both no-
intervention and attention control groups. The small sample size (N = 63) may have limited 
power to detect effects, however. Merry, McDowell, Wild, Bir, and Cunliffe (2004) 
compared RAP with a placebo control group consisting primarily of group arts and crafts 
activities and found some support for the efficacy of RAP relative to placebo, but the effect 
size was small, and effects were not found across different measures of depressive 
symptoms. The placebo condition used by Merry et al. controlled for several factors that are 
1PRP materials are available for use in research. Requests for the curriculum should be made to info@pennproject.org.
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not specific to cognitive–behavioral interventions, including adult attention and 
opportunities to interact with peers. A stronger test of the cognitive–behavioral model would 
control for additional nonspecific factors, such as the discussion of stressors and topics 
relevant to depression.
Shatté (1997) and Reivich (1996) took this approach in their studies, which compared PRP 
with an alternate intervention (the Penn Enhancement Program [PEP]) and a no-intervention 
control. A total of 152 middle school students were randomly assigned to one of the three 
conditions. Group leaders were school teachers, school counselors, and psychology graduate 
students not affiliated with the research team. PRP and PEP both reduced depressive 
symptoms relative to the no-intervention control. PRP and PEP participants’ depression 
scores were not significantly different at most of the follow-up assessments. The lack of 
differences may reflect limited power, as very large cell sizes are often needed to detect 
differences between active interventions. In addition, it is possible that differences would 
have emerged had the researchers followed participants for more than 1 year 
postintervention.
In the present study, we evaluated PRP’s effectiveness as compared with PEP and a no-
intervention control in a large sample (baseline N = 697) over a 3-year follow-up period. 
Our major goals were as follows: (a) to investigate the effectiveness of PRP when delivered 
in schools by school teachers, school counselors, and other group leaders not affiliated with 
a research team, and (b) to evaluate intervention specificity. We examined two 
conceptualizations of depression prevention: (a) reduced levels of symptoms across an 
extended period of time (Jaycox, Reivich, Gillham, & Seligman, 1994), and (b) reduced 
onset of symptoms above a certain threshold (Gillham, Shatté, & Freres, 2000).
Method
Participants
This study was approved by the Institutional Review Board and by school administrators 
and school boards in each of the participating school districts. Figure 1 shows the participant 
flow from recruitment through the 3-year follow-up. Starting in 1997, two consecutive 
cohorts of students participated in this study. Each year, the research team sent letters and 
consent forms describing the project to parents of students in three middle schools 
(henceforth referred to as Schools A, B, and C) in a suburban metropolitan area in the 
United States. Recruitment materials described the study as an investigation of two 
interventions designed to help students cope with day-to-day stressors that are common in 
adolescence. We informed parents that those children who reported elevated symptoms at 
baseline would first be offered spots in the project and that other children would be included 
as space allowed. In total, parents of approximately 4,000 children received recruitment 
materials. Because the response rate was lower than anticipated, we decided to evaluate PRP 
with all children for whom we received consent as long as they were not suffering from a 
depressive disorder at baseline.
A total of 718 children and their parents consented to participate in the project. Response 
rates ranged from 15% to 22% across the three schools. These children completed baseline 
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measures, including the Children’s Depression Inventory (CDI; Kovacs, 2001). The 175 
children with baseline CDI ≥ 13 were administered the depressive disorders section of the 
Diagnostic Interview for Children and Adolescents (Reich, 2000). Eight children scored 
positive for major depressive disorder on the Diagnostic Interview for Children and 
Adolescents and were referred to therapy. Thirteen families dropped from the study after 
baseline and prior to randomization.
The remaining 697 children (376 boys and 321 girls) entered the intervention phase. Within 
cohort and school, we stratified children by grade, gender, and baseline CDI score (on the 
basis of a median split) and then used a computer-generated random numbers sequence to 
randomly assign participants to one of three study conditions: PRP (n = 232), PEP (n = 231), 
or Control (CON; n = 234). Within each school and across all three schools combined, there 
were no significant between-conditions differences on baseline demographic characteristics 
or depressive symptoms.
At baseline, children’s mean age was 12.13 years (SD = 1.03). A total of 268 children (39%) 
were in sixth grade, 237 (34%) were in seventh grade, and 191 (27%) were in eighth grade 
(grade information was missing for 1 student). Age and grade did not significantly differ by 
school. Other demographic characteristics differed by school (see Table 1).
At baseline, mean levels of depressive symptoms (M = 8.45, SD = 7.35, range = 0–45) were 
in the range typically found in community samples (Kovacs, 2001). Mean depressive 
symptoms differed by school, F(1, 694) = 9.52, p < .01. Students in School A (M = 7.03, SD 
= 7.41) reported lower levels of depressive symptoms than those in School B (M = 9.51, SD 
= 7.11) or School C (M = 8.71, SD = 7.34), both ps < .01, whereas children in Schools B and 
C did not differ on baseline depressive symptoms.
Intervention Conditions
PRP (Gillham et al., 1990) is a group intervention that teaches cognitive–behavioral and 
social problem-solving skills. PRP strives to teach students to think flexibly and accurately 
about the challenges and problems that they confront. Students learn about (a) the link 
between beliefs, feelings, and behaviors; (b) cognitive styles, including pessimistic 
explanatory styles; and (c) cognitive restructuring skills, including how to challenge 
negative thinking by evaluating the accuracy of beliefs and generating alternative 
interpretations. Students also learn a variety of techniques for coping and problem-solving, 
including assertiveness, negotiation, decision making, and relaxation. Students apply the 
cognitive and problem-solving techniques in their lives through group discussions and 
weekly homework assignments.
PEP (Reivich, 1996; Shatté, 1997) is a group intervention that focuses on many of the 
stressors associated with adolescent depression. Topics include peer pressure, ethical 
dilemmas, trust and betrayal, improving communication, friendships, family conflict, setting 
and achieving goals, self-esteem, and body image. Each session includes structured 
activities, role-playing, and guided discussion. PEP was designed to control for adult 
attention, group cohesion, social support, the discussion of depression-relevant topics, 
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sharing thoughts and feelings with peers, and engagement in homework and in-session 
activities. A detailed description of PEP is available from the authors on request.
PRP and PEP groups met after school once each week for a total of twelve 90-min sessions. 
Group leaders were school teachers, school counselors, and graduate students in school 
psychology, education, and clinical psychology (not affiliated with the research team) who 
participated in a 30-hr training workshop and biweekly group supervision with the PRP and 
PEP developers. During the study, 19 PRP groups and 19 PEP groups were implemented, 
each containing between 6 and 14 children. Teachers and counselors led 25 groups, and 
graduate students led 11 groups. Because of scheduling difficulties and a shortage of group 
leaders, research team members led one PRP group and one PEP group. No difference was 
found in effects for school staff (teachers and counselors) versus graduate students and 
researchers. Parents of children in PRP and PEP received $5 per session that their child 
attended and a $15 bonus if their child attended at least eight sessions.
In meetings and correspondence with group leaders and potential participants, we described 
both PRP and PEP as interventions that aim to increase well-being and help to buffer 
students against the effects of common stressors. We informed leaders and parents that the 
programs use different strategies to achieve this goal: PRP teaches specific coping and 
problem-solving skills, whereas PEP is more discussion oriented.
Students in the CON condition did not participate in PRP or PEP but completed the same 
assessments as students in the active interventions. In all three conditions, students and their 
families were permitted to seek counseling or therapy.
Intervention Integrity and Attendance
Intervention sessions were audio-recorded. Following the intervention phase, we selected 
four lessons from each group for intervention adherence coding. We chose these lessons 
because they contained key content and included early, middle, and later sessions. Group 
leaders were not informed which lessons would be rated. Two research assistants rated each 
lesson on the presentation of 11–14 concepts, skills, or activities. For each content item, 
raters used a 7-point scale ranging from 1 (no coverage) to 4 (satisfactory coverage) to 7 
(excellent coverage). Interrater reliability for the 1–7 ratings was good (PRP intraclass 
correlation [ICC] = .65; PEP ICC = .77). We computed two integrity scores for each group: 
(a) the degree covered score, calculated by averaging both raters’ integrity item scores for 
each session and then averaging the session averages, and (b) the percentage covered score, 
calculated by averaging the percentage of items covered satisfactorily (≥4) across the 
sessions. Degree covered and percentage covered scores were highly correlated (r = .83, p 
< .01). Integrity scores could not be computed for three PRP and two PEP groups because 
leaders forgot to tape sessions or experienced equipment malfunctions.
Average integrity scores for PRP groups were 4.9 (SD = 0.48) for degree covered and 80% 
(SD = 7.5%) for percentage covered. Average scores for PEP groups were 4.4 (SD = 0.36) 
for degree covered and 68% (SD = 5.7%) for percentage covered. Integrity scores were 
higher for PRP than PEP groups, likely reflecting the increased structure of the PRP 
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curriculum. Mean integrity scores for PRP and PEP groups did not differ significantly by 
school.
On average, the 232 children assigned to PRP attended 6.71 (SD = 4.22) sessions, and the 
231 children assigned to PEP attended 7.11 (SD = 4.43) sessions, t(461) = −1.01, ns. Thirty-
seven children (16%) assigned to PRP and 35 (15%) assigned to PEP did not attend any 
sessions. Of these, 27 in each condition completed at least one follow-up assessment, and 
their data were included in analyses. PRP attendance differed by school, F(1, 231) = 5.58, p 
< .01. Attendance was higher in School A (M = 7.30, SD = 3.97) and School C (M = 7.38, 
SD = 4.04) than School B (M = 5.40, SD = 4.40), ps < .05. PRP attendance was not 
significantly different in Schools A and C. PEP attendance did not differ significantly by 
school.
Assessment Schedule and Depressive Symptom Measures
Children in all three conditions completed questionnaires at baseline and at follow-up 
assessments 2 weeks postintervention and every 6 months thereafter for 3 years. Families 
received $12 for each assessment.
This article focuses on results for the study’s primary outcome variable: depressive 
symptoms, as assessed with the CDI and the Children’s Depression Rating Scale—Revised 
(CDRS–R; Poznanski & Mokros, 1996). The CDI is a widely used measure of depressive 
symptoms in children and adolescents, which has adequate reliability and validity (Kovacs, 
2001). We used recommended cutpoints of CDI greater than or equal to 13 to categorize 
depressive symptoms as at least mild in intensity (referred to as elevated symptoms within), 
and greater than or equal to 19 to denote depressive symptoms as at least moderate in 
intensity (referred to as high symptoms within). These cutpoints are near the 70th and 90th 
percentiles, respectively, for this age group on the basis of the CDI standardization norms 
(Kovacs, 2001).
We also examined clinical symptoms with the CDRS–R. At each follow-up assessment, we 
invited children with a CDI score greater than or equal to 13 to participate in the CDRS–R, a 
semistructured interview assessing symptoms of depression in children and adolescents 
(Poznanski & Mokros, 1996). Trained research assistants conducted the interviews, and a 
second research assistant coded the interview tape for reliability purposes. Interviewers and 
coders were not informed of participants’ condition assignments. Interrater reliability was 
good (ICC = .79). A CDRS–R t score greater than or equal to 65 identified children likely to 
be suffering from a depressive disorder. Clinical psychologists working on the project 
contacted parents of these children to inform them of the assessment results and offer 
referrals. For analytic purposes, children with CDI scores less than 13 were assumed to have 
a CDRS–R t score less than 65.
During the 3-year follow-up, 235 (36%) of the 651 children who completed follow-up 
assessments scored greater than or equal to 13 on the CDI and were invited to interviews at 
one or more follow-up points. Of these 235 children, 62 (20 from PRP, 21 from PEP, and 21 
controls) did not complete CDRS–R interviews and so were excluded from the CDRS–R 
analyses. Thus, CDRS–R analyses used data from 589 children: the 173 children with CDI 
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scores greater than or equal to 13 who completed the interviews and the 416 children who 
consistently scored less than 13 on the CDI during the follow-up.
Data Analytic Strategy
Power analyses—Our goal was to detect small-to-medium intervention effects (d ≥ 0.30) 
allowing for 20% attrition. We planned an initial cell size greater than or equal to 220 (final 
cell size of n ≥ 176) to achieve a power of greater than or equal to .80 to detect a difference 
at α = .05 (two-tailed). Attrition was higher than expected, however, and our final sample 
size at the 3-year follow-up assessment allowed us to detect effect sizes greater than or equal 
to .45 at a power of greater than or equal to .80 and α = .05 (two-tailed).
Inspection and transformation of data—We evaluated assumptions of normality of 
continuous variables by examining histograms and calculating skewness and kurtosis scores 
at each assessment point. CDI scores were skewed at several assessment points so square 
root transformations were used for these data. Table 2 shows raw means to ease 
interpretation.
Attrition and baseline differences—We used analysis of variance (ANOVA) and chi-
square analyses to compare baseline depressive symptoms and demographic characteristics 
of children who did and did not complete any follow-up assessments. The possibility of 
differential attrition was examined by testing for between-conditions differences in these 
variables among children who did not complete any follow-up assessments, as well as 
among children who did not complete the final (3-year) follow-up assessment.
We used ANOVAs and chi-square analyses to compare baseline depressive symptoms and 
demographic characteristics across the three study conditions. These analyses tested for 
differences among all participants who completed baseline (baseline sample) and among 
participants for whom we had follow-up data (follow-up sample).
Intervention effects—We evaluated intervention effects on depressive symptoms using 
intent-to-treat analyses that included data from all participants selected into the study who 
completed the baseline assessment and any of the follow-up assessments (the follow-up 
sample). We operationalized prevention in two ways, as (a) prevention of symptoms over 
time, or lower levels of depressive symptoms relative to the comparison group over the 
follow-up period, and (b) prevention of onset of symptoms above specified levels of 
severity: CDI scores greater than or equal to 13 or 19, and CDRS–R t scores greater than or 
equal to 65.
Mixed-model (MM) ANOVAs tested prevention of symptoms over time. These analyses 
predicted depression scores over time from condition with baseline depression scores 
covaried. Additional analyses examined potential school effects by predicting depression 
scores over time from condition, school, and the Condition × School interaction with 
baseline scores covaried. Examination of the model fit statistics, such as the Akaike 
information criterion and the Bayesian information criterion, as well as the likelihood ratio 
tests, for several covariance structures indicated that the unstructured covariance structure 
was appropriate. When the MM ANOVA analyses revealed a significant or marginally 
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significant main effect of condition, t tests (with test statements) compared the estimated 
marginal means for each pair of conditions from the overall MM ANOVA. We also 
conducted analyses of covariance (ANCOVAs) for each assessment (predicting depressive 
symptoms at the given assessment from condition, with baseline depression score covaried) 
to enable comparisons with prevention studies that report effects at each assessment point.
We calculated effect sizes based on Cohen’s d using the difference (PRP minus CON, PRP 
minus PEP) in estimated marginal means. For MM ANOVAs, we divided the difference in 
estimated marginal means by the square root of the covariance estimate following 
recommendations from Raudenbush and Xiao-Feng (2001). For ANCOVAs, we divided the 
difference in estimated marginal means by the pooled standard deviation. Negative effect 
sizes indicate that PRP group depression scores were lower than CON (or PEP) scores over 
the follow-up period. For PEP versus CON comparisons, negative effect sizes indicate lower 
scores in PEP than CON. We used two-tailed alphas. We report significant effects and 
nonsignificant trends (p < .10, referred to as tendencies within).
Chi-square analyses tested prevention of onset of elevated, high, and clinical levels of 
symptoms. Analyses examining prevention of elevated and high levels of symptoms used 
data from participants who scored below the given cutpoint (CDI < 13 and CDI < 19, 
respectively) at baseline.
Hypotheses—We predicted that PRP would prevent depressive symptoms relative to 
CON and PEP. Specifically, we expected that during the follow-up, PRP participants would 
(a) report lower mean levels of depressive symptoms and (b) show lower rates of onset of 
elevated, high, or clinical levels of symptoms than participants in the other conditions.
Results
Overall
Attrition and baseline differences—Of the 697 children who completed baseline, 46 
did not complete any follow-up assessments. These children were evenly distributed across 
the study conditions and represented between 6% and 7% of the children in each condition. 
Children who did not complete any follow-ups were older than the children who completed 
follow-ups, F(1, 663) = 6.99, p < .01. We found no significant between-conditions 
differences in depressive symptoms or demographic characteristics among children who did 
not complete any follow-up assessments.
A total of 396 participants did not complete the final 3-year follow-up assessment. These 
children were evenly distributed across the study conditions and represented between 56% 
and 59% of the baseline samples in each condition. Children who did not complete the 3-
year follow-up assessment were older, came from households with lower incomes, and were 
less likely to have parents who were married than children who completed this assessment, 
F(1, 662) = 5.01, p < .05; F(1, 438) = 5.83, p < .05; and χ2(1, N = 672) = 10.28, p < .01. We 
found no significant between-conditions differences in depressive symptoms or 
demographic characteristics among children who did not complete the final 3-year follow-
up.
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We found no significant differences by condition on baseline depressive symptoms or 
demographic variables in the baseline sample. In the follow-up sample, parents’ marital 
status varied by condition, χ2(6, N = 643) = 13.03, p < .05, with PEP participants less likely 
than PRP participants or controls to have parents whose marital status was listed as “other.” 
PRP and CON conditions did not differ on parental marital status. Analyses covarying 
parents’ marital status are consistent with the outcome analyses reported within.
Intervention effects—PRP did not significantly reduce depressive symptoms over the 
follow-up period relative to CON, t(622) = −1.29, ns, d = −0.09 (95% CI = −0.23, 0.05); or 
PEP, t(623) = −0.31, ns, d = −0.02 (95% CI = −0.16, 0.11). PEP also did not reduce 
depressive symptoms significantly relative to CON, t(628) = −0.97, ns, d = −0.07 (95% CI = 
−0.21, 0.07). ANCOVAs comparing pairs of conditions at each assessment revealed no 
significant intervention effects and only one trend. PRP tended to prevent depressive 
symptoms relative to CON at the 12-month follow-up, F(1, 324) = 3.11, p < .10, d = −0.18 
(95% CI = −0.37, 0.02).
PRP prevented elevated symptoms (onset of CDI ≥ 13) relative to CON, χ2(1, N = 325) = 
5.29, p < .05, odds ratio = .61 (95% CI = 0.40, 0.95), but not PEP, χ2(1, N = 330) = 0.03, ns, 
odds ratio = .96 (95% CI = 0.60, 1.54). PEP prevented elevated symptoms relative to CON, 
χ2(1, N = 333) = 4.64, p < .05, odds ratio = .64 (95% CI = 0.42, 0.98). Among children with 
baseline CDI scores less than 13, 33 (20%) of 161 in PRP, 36 (21%) of 169 in PEP, and 52 
(32%) of 164 in CON scored greater than or equal to 13 at least once over the follow-up. 
There were no significant intervention effects on high (onset of CDI ≥ 19) or clinical 
symptoms (CDRS–R t ≥ 65).
School effects—Intervention effects differed by school. A MM ANOVA predicting 
follow-up CDI scores from condition, school, and the School × Condition interaction (with 
baseline symptoms covaried) revealed no main effect of condition, a significant main effect 
for school, F(1, 617) = 3.16, p < .05, and a significant School = Condition interaction, F(4, 
619) = 2.61, p < .05. Pairwise comparisons indicated that follow-up CDI scores were 
significantly worse in School C than School A ( p < .05), and tended to be worse in School 
B than School A ( p < .10). Follow-up CDI scores in School B and School C did not 
significantly differ.
To locate the source of the School × Condition interaction, we conducted MM ANOVAs 
predicting CDI score from condition, school, and the School × Condition interaction for 
each pair of schools. These analyses revealed no School × Condition interaction for the 
School A and School B comparison but marginal and significant School × Condition 
interactions for the comparisons of School C to Schools A and B, F(2, 419) = 2.89, p = .057, 
and F(2, 445) = 4.16, p < .05, respectively. An analysis predicting CDI from condition, 
School A + B versus C, and their interaction revealed no significant main effect of condition 
but a significant School (A + B vs. C) × Condition interaction, F(2, 609) = 5.11, p < .01. To 
reduce the number of analyses and retain statistical power, we examined outcomes for 
Schools A and B (combined) and School C.
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Schools A and B
Attrition and baseline differences—We found no evidence for differential attrition in 
Schools A and B. One variable—parents’ marital status—differed by condition in the 
baseline sample and in the follow-up sample, χ2(6, N = 411) = 15.02, p < .05, and χ2(6, N = 
392) = 17.10, p < .01, respectively. Parents of PEP participants were more likely to be 
divorced and less likely to list marital status as “other” than parents of PRP participants or 
controls. Parents of PRP participants and controls did not differ on marital status. Analyses 
covarying marital status were consistent with those reported within.
Intervention effects—In Schools A and B, PRP significantly reduced depressive 
symptoms over the follow-up period relative to CON, t(636) = −2.59, p < .05, d = −0.24 
(95% CI = −0.42, −0.06), and PEP, t(629) = −2.03, p < .05, d = −0.18 (95% CI = −0.36, 
−0.01). PEP did not significantly reduce depressive symptoms relative to CON, t(640) = 
−0.59, ns, d = −0.05 (95% CI = −0.24, 0.13). See Table 2 for means and ANCOVAs by 
assessment point.
PRP prevented elevated symptoms (onset of CDI ≥ 13) relative to CON, χ2(1, N = 205) = 
8.03, p < .01, odds ratio = .38 (95% CI = 0.19, 0.75), but not relative to PEP, χ2(1, N = 212) 
= 1.38, ns, odds ratio = .66 (95% CI = 0.32, 1.33). PEP tended to prevent elevated symptoms 
relative to CON, χ2(1, N = 207) = 2.92, p < .10, odds ratio = .58 (95% CI = 0.31, 1.09). 
Among children with baseline CDI less than 13, 16 (15%) of 105 in PRP, 23 (22%) of 107 
in PRP, and 32 (32%) of 100 controls scored greater than or equal to 13 on the CDI at least 
once during the follow-up (see Figure 2). There were no significant intervention effects on 
high symptoms. PRP tended to prevent clinical symptoms relative to CON, χ2(1, N = 237) = 
2.74, p < .10, odds ratio = .51 (95% CI = 0.23, 1.14), but not PEP, χ2(1, N = 243) = 0.01, ns, 
odds ratio = .96 (95% CI = 0.40, 2.30). No difference was found between PEP and CON, 
χ2(1, N = 232) = 2.37, ns, odds ratio = .53 (95% CI = 0.24, 1.20). Across the follow-up 
period, 11 (9%) of 124 children in PRP, 11 (9%) of 119 in PEP, and 18 (16%) of 113 
controls reported clinical symptoms on the CDRS–R.
School C
Attrition and baseline differences—In School C, there were no between-conditions 
differences at baseline, and there was no evidence for differential attrition.
Intervention effects—PRP did not reduce depressive symptoms over the follow-up 
relative to CON, t(585) = 1.29, ns, d = 0.14 (95% CI = −0.08, 0.36). Contrary to our 
expectations, PEP significantly reduced depressive symptoms relative to PRP, t(594) = 2.08, 
p < .05, d = 0.24 (95% CI = 0.01, 0.47). No difference was found between PEP and CON, 
t(592) = −0.86, ns, d = −0.10 (95% CI = −0.32, 0.12). See Table 2 for means and 
ANCOVAs by assessment. There were no significant intervention effects on elevated, high, 
or clinical symptoms (see Figure 2).
Examining the School × Condition Interaction
We looked at the pattern of results on other measures (demographics, intervention integrity, 
attendance) to see whether any of these variables could explain the different effects across 
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schools. Group integrity scores did not differ by school. For most of the variables that 
differed by school, mean levels for School C were between the means of Schools A and B. 
One exception was race/ethnicity. Compared with Schools A and B, School C included a 
higher proportion of Caucasian participants and a lower proportion of participants who 
indicated their race was “other.” MM ANOVAs predicting follow-up CDI scores revealed 
no significant Race × Condition interaction, however. Thus, none of the variables we 
examined explained the differential effects across schools.
Discussion
The full sample findings provide little evidence for PRP’s effectiveness or specificity. PRP 
prevented the onset of elevated symptoms relative to a no-intervention control but not 
relative to PEP (an intervention that controlled for noncognitive–behavioral therapy specific 
factors). PRP did not reduce mean levels of depressive symptoms over the follow-up and did 
not prevent high or clinical levels of symptoms relative to either comparison group. PRP’s 
effects varied by school, however. In two schools, PRP reduced depressive symptoms over 
the follow-up relative to CON and PEP. In contrast, PRP was not effective in the third 
school.
In Schools A and B, PRP’s effects on depressive symptoms were long lasting. PRP 
participants reported fewer depressive symptoms than controls through the 30-month 
follow-up. Effect sizes were moderate at several assessment points. In addition, PRP 
prevented the onset of elevated symptoms and tended to prevent clinical levels of symptoms 
relative to no intervention control.
These findings indicate that school teachers and counselors can be trained to implement the 
intervention effectively and that schools are a viable setting in which to teach depression 
prevention skills. Given that depression is both very common and under-treated in youths 
(Hirschfeld et al., 1997), the importance of these findings should be underscored. Skills-
based depression prevention programs, like PRP, may be an important addition to the 
educational goals of our school systems. By offering programs like PRP, schools may play a 
vital role in preventing a growing national health concern.
An important direction for future research is to determine whether PRP can prevent clinical 
levels of depressive symptoms when delivered by school teachers and counselors. The 
present findings provide more evidence for the prevention of mild-to-moderate depressive 
symptoms than for the prevention of clinical depression. This could reflect several factors, 
including (a) a limit of the PRP intervention, (b) the fact that most of our group leaders did 
not have clinical training and thus may have been unprepared to help the children at greatest 
risk, or (c) the low attendance of many PRP participants. The lack of findings for clinical 
depression also could be a function of statistical power as only a small proportion of 
children reported clinical levels of symptoms during the follow-up period.
PRP’s Inconsistent Effects
Despite the positive findings in Schools A and B, PRP did not prevent depression in School 
C. We were unable to identify the source of the differential effects observed in the present 
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study. Group leaders in the three schools received similar training and supervision, and 
adherence to the PRP and PEP protocols did not vary significantly by school. Children’s 
baseline depression scores, demographic characteristics, and attendance also did not account 
for the differential effects observed. We also are not aware of any differences in school 
services, curriculum, or in events that transpired within schools that could account for the 
discrepancy. Subtle differences among the schools in program endorsements, students’ 
needs, or general school climate may have enhanced PRP’s effectiveness in two schools 
and/or hindered its effectiveness in the third.
The inconsistency in PRP’s effects within the present study mirrors its inconsistent effects 
across studies. PRP has reduced and prevented depressive symptoms relative to control in 
several studies (e.g., Gillham, Reivich, Jaycox, & Seligman, 1995; Yu & Seligman, 2002). 
For example, in the original evaluation of PRP, PRP halved the rate of moderate to severe 
symptoms. Effect sizes were moderate to large (d > 0.60) 12–24 months postintervention 
(Gillham et al., 1995). However, other studies failed to replicate these findings (e.g., 
Pattison & Lynd-Stevenson, 2001; Roberts, Kane, Bishop, & Matthews, 2004). A review of 
PRP research suggests that PRP’s effects are strongest when group leaders are the 
intervention developers, members of their research team, and graduate students who receive 
extensive training and supervision from the intervention developers. PRP’s effects on 
depression are often smaller or nonsignificant when group leaders are school teachers, 
clinicians, or other researchers not affiliated with the PRP laboratory (Gillham, Hamilton, 
Freres, Patton, & Gallop, 2006). In other words, as research on PRP moves along the path 
from efficacy to real world implementation, intervention effects wane or become 
inconsistent. This pattern corresponds with recent findings for the RAP intervention (Harnett 
& Dadds, 2004) and with the observation that psychological interventions that yield 
substantial effects in research settings often produce small or no effects when delivered by 
community providers (Weisz, Donenberg, Han, & Weiss, 1995). A critical priority for 
prevention research is the development of effective dissemination strategies.
Specificity
The School A and School B findings provide some support for specificity as mean 
depression scores were lower in PRP than PEP participants over the follow-up. Contrary to 
our expectations, however, PEP participants reported fewer depressive symptoms over the 
follow-up than PRP participants in School C. Because PRP was not beneficial relative to 
CON in School C, it is unclear whether PEP’s superiority reflects the limited value of 
cognitive–behavioral skills or a more general failure of the PRP intervention in that school.
Limitations
The study’s limits include the low recruitment rate, substantial attrition, incomplete 
assessment of clinical depression, and the inclusion of graduate students as group leaders. In 
each school, fewer than 25% of students enrolled in the study. Enrollment rates were so 
much lower than we expected that we revised our original plan to select children with 
elevated symptoms and offered the program to all children who were not clinically 
depressed at the start of the study. The children who enrolled reported a wide range of 
symptoms at baseline, but we did not evaluate the interventions as delivered to most school 
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students in a school setting as in the recent study by Spence, Sheffield, and Donovan (2005). 
Our participants’ demographic characteristics reflected the communities from which they 
came, but it is likely that these children (and their parents) differed in other important ways 
from those who did not sign up for the study. This limits the extent to which we can 
generalize from our findings.
Fewer than 50% of the original baseline sample completed the 3-year follow-up. Attrition 
was due to vicissitudes across schools but did not seem to vary by condition. For example, 
in School A, because of a change in administration, school staff stopped reminding children 
to attend assessment sessions. School B has had a high student attrition rate in general, with 
10%–20% of students leaving the school each year. We tried to follow participants who 
moved through the mail, but compliance with these assessments was low, and we were often 
unable to find forwarding addresses. Attrition and noncompletion of assessments are 
common problems in longitudinal depression prevention studies. Attrition is often 40% or 
more in studies with 3 and 4 years of follow-up (e.g., Roberts et al., 2004; Spence et al., 
2005). In our current work, we are implementing several strategies to minimize attrition, 
including increased incentives for complete assessments and strategies for tracking 
participants, such as requesting contact information for relatives.
Because of budget and staffing constraints, CDRS–R interviews were only conducted with 
children with elevated CDI scores (CDI ≥ 13). CDI manual norms suggest that 8% of 
children who score below this cutpoint may have depressive disorders (Kovacs, 2001). In 
addition, only about 75% of children who were invited to interviews actually participated. 
Thus, we probably failed to detect clinical levels of symptoms in several children. During 
the study, we became concerned about another possible limitation of the triggered interview 
procedure—that it influenced questionnaire responses. Children may have become aware 
that elevated questionnaire scores triggered interviews, and children who wanted to avoid 
interviews may have endorsed few symptoms of depression on the CDI. It is striking that 
during a developmental phase when depression rates generally increase (Angold, Costello, 
& Worthman, 1998), depressive symptoms declined in all three conditions in our sample. In 
the end, the triggered interviews may have limited our ability to find intervention effects on 
both depression measures.
The inclusion of graduate students as group leaders is also somewhat problematic. The 
graduate students who led groups were not affiliated with our research laboratory and most 
planned to pursue careers as school psychologists or school counselors. Still, these graduate 
students may differ from the school personnel who would deliver an intervention like PRP 
once disseminated. An important finding is that analyses revealed no significant differences 
in intervention effects for graduate students versus school teachers and counselors.
Future research may also benefit from more sophisticated analyses of intervention 
implementation. Our intervention integrity scoring system weighted specific content items 
equally, but it is likely that some skills are more beneficial or require more explanation and 
discussion than others. An examination of the relationship between specific content covered 
and intervention outcome could yield valuable information about the mechanisms of PRP’s 
effects and help set priorities for group leader training and supervision.
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Our integrity coding system was designed to measure leaders’ adherence to the intervention 
protocol and probably did not fully capture the variability in leaders’ competence, or skill, in 
intervention delivery (McGlinchey & Dobson, 2003). Although competence and adherence 
are related, competent leaders may sacrifice adherence at times to allow for more in-depth 
discussion of group members’ specific problems, review of concepts that seem confusing to 
group members, or more attention to group process. An assessment of competence could 
help to explain our differential findings; it may be that PRP group leaders in School C 
adhered to the manual but did not show true competence.
Clinical Significance
We found little evidence for PRP’s effectiveness or specificity in preventing depression in 
the full sample. However, in two of the three schools, PRP reduced depressive symptoms 
over a 2.5-year period and prevented elevated depressive symptoms. This suggests that PRP 
can have long-lasting effects when delivered by school teachers, counselors, and other 
providers in a school setting. Although PRP’s effects are inconsistent, we believe that 
research that evaluates interventions in real world settings will lead to the development of 
dissemination procedures that enable schools to include powerful depression prevention 
programs as part of their educational mission.
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Figure 1. 
Flow diagram of recruitment, screening, and follow-up. CDI = Children’s Depression 
Inventory; DICA-R = depressive disorders section of the Diagnostic Interview for Children 
and Adolescents; MD = major depressive disorder; PRP = Penn Resiliency Program; PEP = 
Penn Enhancement Program; CON = control; post = postintervention.
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Figure 2. 
Onset of elevated symptoms by school: Cumulative proportion of participants with a 
Children’s Depression Inventory score greater than or equal to 13. PRP = Penn Resiliency 
Program; PEP = Penn Enhancement Program; CON = Control; pre = preintervention; post = 
postintervention.
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